Netherlands· NL-f0d2be36d920
Moxifloxacine Stulln zonder conserveermiddel 5 mg/ml, oogdruppels, oplossing in verpakking voor éénmalig gebruik
A moxifloxacin product containing moxifloxacinehydrochloride, registered in Netherlands by Pharma Stulln GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 12 of 19 countries.
Countries holding a registration under ATC S01AE07 (moxifloxacin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Moxifloxacin · ATC S01AE07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MOXIFLOXACINEHYDROCHLORIDE
- Manufacturer
- Pharma Stulln GmbH
- Country
- Netherlands (NL)
- ATC code
- S01AE07
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.57 mg, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id126652
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMoxifloxacinLupin Pharmaceuticals, Inc.
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaMOXIFLOXACIN BROWN & BURKBrown & Burk IR Limited, Dublin
- SwedenVigamox 5 mg/ml Ögondroppar, lösningNovartis Sverige AB
- NorwayVigamoxNovartis
- IcelandVigamoxNovartis Healthcare A/S
- FinlandVigamoxNovartis Finland Oy
- BelgiumKanavig 5 mg/mlNovartis Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- United Kingdom (Northern Ireland) · Avelox, Moxidox
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dffae732-21df-4442-abc9-b9b3b5d60919 GET /v1/drugs/dffae732-21df-4442-abc9-b9b3b5d60919?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126652_smpc.pdf",
"strength": null,
"atc_label": "Moxifloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126652",
"excipients": [
"BOORZUUR (E 284)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"MOXIFLOXACINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126652.pdf",
"authorised_at": "2021/12/16",
"procedure_number": "AT/H/1085/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "126652",
"additional_monitoring": "N"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.